What we're reading, August 17, 2016: Walgreens looks to gamify medication adherence; Aetna warned the Department of Justice that if its merger wasn't approved, it would pull back from exchange participation; and the controversy behind numbers of medication error deaths.
Walgreens customers will have the opportunity to earn points for discounts if they are adherent to their medications. According to The Chicago Tribune, Walgreens will offer a free digital health program for patients on certain drugs to earn points and compare how well they are doing against other anonymous “players.” The game awards points for taking medications on time, for refilling prescriptions, and for taking quizzes about their conditions and medications. When the program starts, it will be limited to certain diabetes patients.
Aetna has warned that Department of Justice (DOJ) that if its proposal to buy Humana is to approved, it will leave much of the Affordable Care Act’s exchanges. Aetna’s CEO wrote in a letter to the DOJ that if the transaction is blocked, it would “have a negative financial impact” and Aetna would not be able to continue supporting the exchanges set up under President Obama’s healthcare reform law, reported Reuters. Since that letter was sent, July 5, Aetna has made the decision to pull back its involvement in the exchanges.
Reports on deaths resulting from medication errors can be controversial. In a post for The New York Times’ The Upshot, Aaron E. Carroll, MD, MS, tries to provide some context for the attention-grabbing statistics that tend to make headlines. He notes that it can be very difficult to prove what events cause death and which events are correlated with a death. In addition, the potential harms of going to the hospital may not outweigh the potential benefits of being treated.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More